Canopy Rivers Invests US$10M in Plant Researcher ZeaKal

Canopy Rivers announced an investment of US$10 million for California-based plant research company ZeaKal.

Canopy Growth Inks Offtake Deal with PharmHouse

Canopy Growth signed an off-take agreement with PharmHouse, a partly owned joint venture of its subsidiary Canopy Rivers.

Notes from the Floor: Benzinga Cannabis Capital Conference

INN brings investors a recap of some of the highlights from the Benzinga Cannabis Capital Conference in Toronto.

Canopy Growth to Inject $30 Million in Additional Capital into Canopy Rivers

Canopy Growth (TSX:WEED) has announced it will increase its investment into Canopy Rivers (TSXV:RIV) by C$30 million. As quoted in...

Key Cannabis Players Launch Venture Capital Companies

Canopy Rivers and Australis, new public cannabis investment companies from two of Canada's major producers, are hitting the public market...

Cannabis ETFs — Should You Invest?

Cannabis stocks can be precarious, but what about cannabis ETFs? Here's a look at why investors may want to consider...